{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:28:19Z","timestamp":1765758499531,"version":"3.37.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T00:00:00Z","timestamp":1515628800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s40256-017-0261-0","type":"journal-article","created":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T05:58:39Z","timestamp":1515650319000},"page":"223-229","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Comparison of Warfarin Requirements in Post-cardiac Surgery Patients: Valve Replacement Versus Non-valve Replacement"],"prefix":"10.1007","volume":"18","author":[{"given":"Logan M.","family":"Olson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea M.","family":"Nei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Joyce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narith N.","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ross A.","family":"Dierkhising","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott D.","family":"Nei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,11]]},"reference":[{"key":"261_CR1","unstructured":"Duke Clinical Research Institute. STS General Thoracic Surgery Database Executive Summary: January 2002\u2013December 2015 Procedures. http:\/\/www.sts.org\/national-database\/database-managers\/executive-summaries. Published Spring 2016. Accessed Aug 15, 2016."},{"issue":"20","key":"261_CR2","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1056\/NEJMoa1602002","volume":"374","author":"AM Gillinov","year":"2016","unstructured":"Gillinov AM, Bagiella E, Moskowitz AJ, Raiten JM, Groh MA, Bowdish ME, et al. Rate control versus rhythm control for atrial fibrillation after cardiac surgery. N Engl J Med. 2016;374(20):1911\u201321.","journal-title":"N Engl J Med."},{"issue":"3","key":"261_CR3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1345\/aph.1G407","volume":"40","author":"M Rahman","year":"2006","unstructured":"Rahman M, BinEsmael TM, Payne N, Butchart EG. Increased sensitivity to warfarin after heart valve replacement. Ann Pharmacother. 2006;40(3):397\u2013401.","journal-title":"Ann Pharmacother."},{"issue":"23","key":"261_CR4","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.1161\/CIR.0000000000000041","volume":"130","author":"CT January","year":"2014","unstructured":"January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, et al. AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014;130(23):e199\u2013267.","journal-title":"Circulation."},{"issue":"4","key":"261_CR5","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1067\/mtc.2002.121162","volume":"123","author":"EG Butchart","year":"2002","unstructured":"Butchart EG, Payne N, Li HH, Buchan K, Mandana K, Grunkemeier GL. Better anticoagulation control improves survival after valve replacement. J Thorac Cardiovasc Surg. 2002;123(4):715\u201323.","journal-title":"J Thorac Cardiovasc Surg."},{"issue":"6","key":"261_CR6","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1378\/chest.127.6.2049","volume":"127","author":"D Garcia","year":"2005","unstructured":"Garcia D, Regan S, Crowther M, Hughes RA, Hylek EM. Warfarin maintenance dosing patterns in clinical practice: implications for safer anticoagulation in the elderly population. Chest. 2005;127(6):2049\u201356.","journal-title":"Chest."},{"issue":"11","key":"261_CR7","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/phar.1280","volume":"33","author":"TM Berg","year":"2013","unstructured":"Berg TM, O\u2019Meara JG, Ou NN, Daniels PR, Moriarty JP, Bergstrahl EJ, et al. Risk factors for excessive anticoagulation among hospitalized adults receiving warfarin therapy using a pharmacist-managed dosing protocol. Pharmacotherapy. 2013;33(11):1165\u201374.","journal-title":"Pharmacotherapy."},{"issue":"9","key":"261_CR8","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1177\/1060028015590438","volume":"49","author":"M Campo del","year":"2015","unstructured":"del Campo M, Roberts G. Changes in warfarin sensitivity during decompensated heart failure and chronic obstructive pulmonary disease. Ann Pharmacother. 2015;49(9):962\u20138.","journal-title":"Ann Pharmacother."},{"issue":"4","key":"261_CR9","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/j.1875-9114.1998.tb03909.x","volume":"18","author":"JP Rose","year":"1998","unstructured":"Rose JP, Rihn TL, Long SF. Warfarin sensitivity after mechanical heart valve replacement. Pharmacotherapy. 1998;18(4):856\u20139.","journal-title":"Pharmacotherapy."},{"issue":"8","key":"261_CR10","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0002-9149(99)00463-4","volume":"84","author":"W Ageno","year":"1999","unstructured":"Ageno W, Turpie AG. Exaggerated initial response to warfarin following heart valve replacement. Am J Cardiol. 1999;84(8):905\u20138.","journal-title":"Am J Cardiol."},{"issue":"3","key":"261_CR11","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.thromres.2009.02.012","volume":"125","author":"K Meijer","year":"2010","unstructured":"Meijer K, Kim YK, Schulman S. Decreasing warfarin sensitivity during the first three months after heart valve surgery: implications for dosing. Thromb Res. 2010;125(3):224\u20139.","journal-title":"Thromb Res."},{"issue":"1","key":"261_CR12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0002-9149(01)01582-X","volume":"88","author":"W Ageno","year":"2001","unstructured":"Ageno W, Turpie AG, Steidl L, Ambrosini F, Cattaneo R, Codari RL, et al. Comparison of a daily fixed 2.5-mg warfarin dose with a 5-mg, international normalized ratio adjusted, warfarin dose initially following heart valve replacement. Am J Cardiol. 2001;88(1):40\u20134.","journal-title":"Am J Cardiol."},{"issue":"12","key":"261_CR13","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.7326\/0003-4819-135-12-200112180-00010","volume":"135","author":"WH Maisel","year":"2001","unstructured":"Maisel WH, Rawn JD, Stevenson WG. Atrial fibrillation after cardiac surgery. Ann Intern Med. 2001;135(12):1061\u201373.","journal-title":"Ann Intern Med."},{"key":"261_CR14","doi-asserted-by":"crossref","first-page":"203179","DOI":"10.5402\/2011\/203179","volume":"2011","author":"C Chelazzi","year":"2011","unstructured":"Chelazzi C, Villa G, De Gaudio AR. Postoperative atrial fibrillation. ISRN Cardiol. 2011;2011:203179.","journal-title":"ISRN Cardiol."},{"issue":"8","key":"261_CR15","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jacc.2007.10.043","volume":"51","author":"N Echahidi","year":"2008","unstructured":"Echahidi N, Pibarot P, O\u2019Hara G, Mathieu P. Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery. J Am Coll Cardiol. 2008;51(8):793\u2013801.","journal-title":"J Am Coll Cardiol."},{"issue":"1","key":"261_CR16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ccl.2008.09.011","volume":"27","author":"K Jongnarangsin","year":"2009","unstructured":"Jongnarangsin K, Oral H. Postoperative atrial fibrillation. Cardiol Clin. 2009;27(1):69\u201378 viii.","journal-title":"Cardiol Clin."},{"issue":"3","key":"261_CR17","doi-asserted-by":"crossref","first-page":"196","DOI":"10.4103\/0971-9784.69047","volume":"13","author":"SG Nair","year":"2010","unstructured":"Nair SG. Atrial fibrillation after cardiac surgery. Ann Cardiac Anaesth. 2010;13(3):196\u2013205.","journal-title":"Ann Cardiac Anaesth."},{"issue":"2 Suppl","key":"261_CR18","doi-asserted-by":"crossref","first-page":"e576S","DOI":"10.1378\/chest.11-2305","volume":"141","author":"RP Whitlock","year":"2012","unstructured":"Whitlock RP, Sun JC, Fremes SE, Rubens FD, American College of Chest P. Teoh KH Antithrombotic and thrombolytic therapy for valvular disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e576S\u2013600S.","journal-title":"Chest."},{"issue":"2 Suppl","key":"261_CR19","doi-asserted-by":"crossref","first-page":"e44S","DOI":"10.1378\/chest.11-2292","volume":"141","author":"W Ageno","year":"2012","unstructured":"Ageno W, Gallus AS, Wittkowsky A, Crowther M, Hylek EM, Palareti G. Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e44S\u201388S.","journal-title":"Chest."},{"issue":"2 Suppl","key":"261_CR20","doi-asserted-by":"crossref","first-page":"e152S","DOI":"10.1378\/chest.11-2295","volume":"141","author":"A Holbrook","year":"2012","unstructured":"Holbrook A, Schulman S, Witt DM, Vandvik PO, Fish J, Kovacs MJ, et al. Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e152S\u201384S.","journal-title":"Chest."}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40256-017-0261-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-017-0261-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-017-0261-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T12:17:08Z","timestamp":1719749828000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40256-017-0261-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,11]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["261"],"URL":"https:\/\/doi.org\/10.1007\/s40256-017-0261-0","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"type":"print","value":"1175-3277"},{"type":"electronic","value":"1179-187X"}],"subject":[],"published":{"date-parts":[[2018,1,11]]}}}